Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies999
AlzeCure Pharma AB
AlzeCure Foundation develops novel diagnostics and therapeutics for neurodegenerative disorders.
Sector
Subsector
Keywords
Location
Catalyst Pharmaceuticals Partners
Catalyst Pharmaceuticals develops therapies for rare neuromuscular and neurological diseases.
Sector
Subsector
Location
total rounds
total raised
Neurmedix
Neurmedix develops therapeutics for neurodegenerative and oncological diseases.
Sector
Subsector
Keywords
Alzprotect
AlzProtect is a biopharmaceutical company developing new bioactive molecules for neurodegenerative diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 17.01.2019. Their latest investor National Institutes of Health. Their latest round Grant
Alzheimer's Association
The Alzheimer's Association provides global support and research for Alzheimer's and dementia.
Sector
Subsector
Keywords
Location
count Of Investments
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Pfizer
Pfizer is a company that provides safe, effective, and affordable medicines and healthcare services.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
AbbVie
AbbVie discovers and delivers innovative medicines to solve health issues.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Takeda
Takeda Pharmaceutical Company Limited markets a range of original products in the healthcare industry.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Pfizer
Pfizer is a company that provides safe, effective, and affordable medicines and healthcare services.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
People
Founders1
Glenn Larsen
Glenn Larsen is a Co-Founder, President & Chief Executive Officer at Aquinnah Pharmaceuticals since 2014. Aquinnah is a pharmaceutical company focused on the development of new therapies for ALS and neurodegenerative diseases. Glenn brings significant experience from his tenure in the discovery, development and commercialization of pharmaceutical, biotech and regenerative medicines, including raising approximately $65 million in private venture funding. Glenn has been closely involved with the commercial registration of five biologics and led teams that advanced over 15 new biologic and small molecule chemical entities to clinical development. Previously, Glenn was the Vice President of Musculoskeletal Sciences at Wyeth (Pfizer); directing R&D in the fields of arthritis, pain, inflammation and tissue regeneration, including responsibility for the global development and commercial efforts of Enbrel, an anti-TNF therapeutic. Glenn also served as Vice President of Preclinical Research and Development at Genetics Institute, responsible for all preclinical activities needed to identify and advance drug candidates to clinical trials for evaluation in the fields of oncology, inflammation, immunology, hemophilia, hematopoiesis and tissue regeneration programs. Glenn currently serves on the Board of Directors of Aquinnah Pharmaceuticals, Anika Therapeutics, 180 Therapeutics and previously Hydra Biosciences; and has held prior senior executive leadership roles at Hydra Biosciences and SpringLeaf Therapeutics. Glenn received his Ph.D. in Biochemistry from Stony Brook University and is a PMD Graduate of Harvard Business School.
current job
organization founded
Glenn Larsen
Employee Profiles2
Benjamin Wolozin
Co-Founder and the Chief Scientific Officer